NCT04496076View on ClinicalTrials.gov

COVID-19 Brain Injury

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 2, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

May 31, 2021

Conditions
Sars-CoV2Severe Neurologic InjuryIschemic StrokeHemorrhagic StrokeIntracerebral HemorrhageSubarachnoid HemorrhageTraumatic Brain InjuryStatus Epilepticus
Trial Locations (1)

15261

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT04496076 - COVID-19 Brain Injury | Biotech Hunter | Biotech Hunter